{"id":"W4365512356","doi":"10.1158/1538-7445.am2023-ct124","title":"Abstract CT124: A first-in-clinic phase 1 study of GSK3745417 STING agonist in relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Sting; Tolerability; Myelodysplastic syndromes; Leukemia; Stimulator of interferon genes; Internal medicine; Bone marrow; Cancer research; Immunology; Oncology; Pharmacology; Immune system; Adverse effect; Innate immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008753159,0.001338353,0.001860594,0.0004199522,0.0004091035,0.00108373,0.0009480069,0.001297624,0.008080247],"category_scores_gemma":[0.000593567,0.0004798438,0.001287845,0.0003938456,0.0006230429,0.0006514569,0.0003317948,0.00364853,0.00188871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008496037,"about_ca_system_score_gemma":0.001331447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001067913,"about_ca_topic_score_gemma":0.003218316,"domain_scores_codex":[0.9997867,0.00006883992,0.00001485952,0.00004530366,0.00003013273,0.00005409515],"domain_scores_gemma":[0.9996542,0.00003461432,0.00004925589,0.00002821106,0.00003574752,0.0001980066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.279099,0.09199964,0.0083176,0.006155115,0.00450356,0.001594625,0.0007008935,0.00713162,0.2448811,0.001550066,0.04856978,0.305497],"study_design_scores_gemma":[0.4131982,0.5312785,0.01558034,0.0002663491,0.001367179,0.001635238,0.0001474607,0.002869939,0.01360303,0.0006187096,0.01934497,0.00009013077],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9669716,0.01180541,0.001386696,0.001896704,0.0005088183,0.005195969,0.005247079,0.0005535483,0.006434088],"genre_scores_gemma":[0.9671916,0.007285245,0.002448288,0.002678703,0.0002352709,0.00406426,0.007326422,0.00008794518,0.008682107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008080247,"threshold_uncertainty_score":0.02703112,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05234164559355544,"score_gpt":0.3799489385241098,"score_spread":0.3276072929305544,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}